.jpg)
- Cancer investigation
-
影響因子：
2.238
-
I S S N：
0735-7907
-
出 版 社：
Informa Healthcare
-
出 版 地：
London
-
出版國(guó)家：
England
-
刊 期：
雙月刊
-
創(chuàng)刊時(shí)間：
1983
-
語 種：
英文
-
審稿周期：
平均8.5月
-
中科院分區(qū)：
4
-
投稿命中率：
命中率約50%
-
國(guó)外數(shù)據(jù)庫收錄：
IM
-
中國(guó)收錄文章數(shù)：
101
-
5年影響因子：
2.269
-
研究領(lǐng)域：
腫瘤學(xué)
-
官方鏈接：
http://informahealthcare.com/loi/cnv
-
投稿須知：
http://informahealthcare.com/loi/cnv
期刊介紹：
With nearly 18,000 subscribers worldwide, Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.
